BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17299629)

  • 1. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
    Lu J; Yoshida O; Hayashi S; Arimoto H
    Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
    Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
    J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
    Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
    Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model.
    Goldstein BP; Wei J; Greenberg K; Novick R
    J Antimicrob Chemother; 1998 Aug; 42(2):277-8. PubMed ID: 9738856
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
    Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
    J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
    Jain RK; Trias J; Ellman JA
    J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.
    Nicolaou KC; Hughes R; Cho SY; Winssinger N; Labischinski H; Endermann R
    Chemistry; 2001 Sep; 7(17):3824-43. PubMed ID: 11575783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
    Yanagihara K; Ohnishi Y; Morinaga Y; Nakamura S; Kurihara S; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    Int J Antimicrob Agents; 2008 Nov; 32(5):401-4. PubMed ID: 18715761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
    Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
    J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of nocathiacin I analogues.
    Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3545-9. PubMed ID: 16621551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK).
    Martínez-Botella G; Breen JN; Duffy JE; Dumas J; Geng B; Gowers IK; Green OM; Guler S; Hentemann MF; Hernandez-Juan FA; Joseph-McCarthy D; Kawatkar S; Larsen NA; Lazari O; Loch JT; Macritchie JA; McKenzie AR; Newman JV; Olivier NB; Otterson LG; Owens AP; Read J; Sheppard DW; Keating TA
    J Med Chem; 2012 Nov; 55(22):10010-21. PubMed ID: 23043329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.